Oditrasertib

N/A

Report date: 2025/05/26 20:01:03
NME

Base Information

Drug NameOditrasertib
Drug Alias NameSAR-443820DNL-788RA15804589DN-2489DN-0002489 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor-interacting serine/threonine-protein kinase 1 inhibitors
TargetsReceptor-interacting serine/threonine-protein kinase 1
Therapy Area/IndicationsAmyotrophic Lateral SclerosisMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[16] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaIND
Originator CompaniesHarvard University
China Registration ClassN/A

Develop Information

Active CompaniesSanofiSanofi-Aventis Recherche & DeveloppementSanofi (China) Investment Co Ltd
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A